Yahoo · Aug 23, 2026
What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer
Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.
NASDAQ · CAH
Cardinal Health, Inc.
Healthcare · Medical - Distribution
$234.55
Down-$0.58 (-0.25%)
Updated Aug 31, 2026, 12:45 PM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 47.1B
- P/E ratio
- 29.58
- Dividend yield
- 1.08%
- 52-week range
- $180.45 – $258.30
- Volume
- 1.78M
- Avg. volume
- 2.49M
Price performance
CAH price history
1M range · 20 trading sessions · Daily adjusted prices
CAH closed at $234.55 after 20 trading sessions, down 0.45% for the selected period.
- Last close
- $234.55
- Period change
- -0.45%
- Period low
- $228.46
- Period high
- $240.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $236.02 | $236.80 | $233.72 | $234.55 | 1.78M |
| Aug 27, 2026 | $236.49 | $237.30 | $234.15 | $235.13 | 1.03M |
| Aug 26, 2026 | $237.90 | $240.88 | $236.445 | $238.40 | 1.47M |
| Aug 25, 2026 | $232.51 | $238.10 | $232.375 | $237.92 | 1.34M |
| Aug 24, 2026 | $229.16 | $232.37 | $227.68 | $232.37 | 1.4M |
| Aug 21, 2026 | $228.80 | $231.29 | $228.16 | $229.51 | 1.39M |
| Aug 20, 2026 | $232.25 | $235.00 | $228.38 | $228.46 | 1.59M |
| Aug 19, 2026 | $236.41 | $238.15 | $232.34 | $234.85 | 1.38M |
| Aug 18, 2026 | $235.17 | $238.24 | $233.94 | $234.98 | 1.79M |
| Aug 17, 2026 | $233.55 | $238.94 | $233.55 | $235.66 | 1.8M |
| Aug 14, 2026 | $230.91 | $235.27 | $229.33 | $235.17 | 1.69M |
| Aug 13, 2026 | $233.00 | $235.67 | $229.36 | $231.24 | 2.85M |
| Aug 12, 2026 | $239.75 | $239.75 | $233.49 | $234.16 | 1.91M |
| Aug 11, 2026 | $243.00 | $258.3021 | $236.48 | $240.26 | 3.01M |
| Aug 10, 2026 | $236.32 | $239.54 | $235.00 | $237.18 | 2.3M |
| Aug 7, 2026 | $237.23 | $239.85 | $236.30 | $236.40 | 1.55M |
| Aug 6, 2026 | $244.01 | $244.87 | $233.99 | $237.66 | 1.8M |
| Aug 5, 2026 | $235.13 | $239.545 | $235.01 | $239.23 | 2.65M |
| Aug 4, 2026 | $234.31 | $235.76 | $231.1425 | $233.55 | 2.58M |
| Aug 3, 2026 | $230.39 | $235.72 | $229.605 | $235.60 | 2.09M |
Latest CAH news
The latest Smart Investors Daily articles mentioning CAH.
Stock researchCompany · Overview
CAH research
Overview
Company profile and research snapshot.
Company profile
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $211.22
- Implied upside
- —
- Analysts
- 13
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | RBC Capital | Outperform | — |
| Aug 13, 2026 | JP Morgan | Neutral | — |
| Aug 13, 2026 | TD Cowen | Buy | — |
| Aug 13, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Morgan Stanley | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 23, 2026
Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know
Alt divested part of his direct equity stake after the stock surged 57% over the past year, retaining 20,495 shares worth $4.82 million.
Yahoo · Aug 23, 2026
Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.
Yahoo · Aug 23, 2026
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
